MIRM (STOCKS)
Mirum Pharmaceuticals, Inc. Common Stock
$96.490000
+1.290000 (+1.36%)
Prev close: $95.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher Peetz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,820.55M
- Employees
- 355
- P/E (TTM)
- -201.82
- P/B (TTM)
- 15.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $521.31M |
| Benefits Costs and Expenses | $542.74M |
| Costs And Expenses | $542.74M |
| Operating Expenses | $543.45M |
| Selling, General, and Administrative Expenses | $257.03M |
| Other Operating Expenses | $286.42M |
| Operating Income/Loss | -$22.14M |
| Income/Loss From Continuing Operations After Tax | -$23.36M |
| Income/Loss From Continuing Operations Before Tax | -$21.43M |
| Income Tax Expense/Benefit | $1.94M |
| Income Tax Expense/Benefit, Current | $1.94M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$23.36M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$23.36M |
| Net Income/Loss Available To Common Stockholders, Basic | -$23.36M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.47 |
| Diluted Earnings Per Share | -$0.47 |
| Basic Average Shares | 50,198,304 |
| Diluted Average Shares | 50,198,304 |
| Assets | $842.81M |
| Current Assets | $549.68M |
| Inventory | $24.89M |
| Other Current Assets | $524.80M |
| Noncurrent Assets | $293.13M |
| Fixed Assets | $1.86M |
| Intangible Assets | $260.92M |
| Other Non-current Assets | $30.35M |
| Liabilities | $528.12M |
| Current Liabilities | $205.80M |
| Accounts Payable | $9.61M |
| Wages | $47.28M |
| Other Current Liabilities | $148.91M |
| Noncurrent Liabilities | $322.32M |
| Equity | $314.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $314.69M |
| Liabilities And Equity | $842.81M |
| Net Cash Flow From Operating Activities | $55.83M |
| Net Cash Flow From Operating Activities, Continuing | $55.83M |
| Net Cash Flow From Investing Activities | -$23.95M |
| Net Cash Flow From Investing Activities, Continuing | -$23.95M |
| Net Cash Flow From Financing Activities | $40.14M |
| Net Cash Flow From Financing Activities, Continuing | $40.14M |
| Net Cash Flow | $72.02M |
| Net Cash Flow, Continuing | $72.02M |
| Comprehensive Income/Loss | -$22.64M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.64M |
| Other Comprehensive Income/Loss | $724.00K |